FDA Agrees to Remove Anti-Ivermectin Posts Off the Internet in Lawsuit Settlement

Ivermectin

The Food and Drug Administration (FDA) has reportedly settled a lawsuit brought by three doctors who accused the health regulator of interfering with their ability to practice medicine and prescribe Ivermectin to treat COVID.

Dr. Mary Talley Bowden, Dr. Paul E. Marik and Dr. Robert L. Apter sued the FDA in June of 2022, asking the court to: “Hold unlawful and set aside any FDA actions directing or opining on whether ivermectin should be used for certain off-label purposes, including treatment of COVID-19.”

Read More

Feds Conceal Details About Anti-Ivermectin Campaign in Response to Doctors’ Reinstated Lawsuit

Ivermectin

The Food and Drug Administration wants to continue its selective promotion of off-label drug use: good for COVID-19 vaccines, bad for alternatives to those vaccines. It just doesn’t want the public to see its full reasoning for the latter.

The FDA and the Department of Health and Human Services filed a renewed motion to dismiss a lawsuit by doctors claiming  the agencies have a practice of demonizing ivermectin by conflating its human and animal doses and using “command” language, such as “stop it,” to discourage using the anti-parasite drug against COVID.

Read More

Appeals Court Says FDA Denunciations of Ivermectin Look Like ‘Command,’ not Advice

The Food and Drug Administration (FDA)  is claiming in federal court that it never told doctors not to prescribe ivermectin to treat COVID-19. Federal judges aren’t buying it, and state medical boards that rely heavily on FDA guidance continue to investigate doctors for such prescriptions.

Echoing a federal district judge nine months ago, a three-judge panel of the 5th U.S. Circuit Court of Appeals pressed a Justice Department lawyer to reconcile the FDA’s repeated public denunciations of ivermectin as an off-label COVID treatment with its insistence that the agency is not liable for resulting investigations of doctors who prescribe or promote it.

Read More

New Hampshire House Passes Bill Allowing Pharmacists to Dispense Ivermectin Without a Prescription

New Hampshire may become the first state to allow the antiparasitic drug ivermectin to be obtained without a prescription. A Republican-sponsored ivermectin bill (HB 1022) passed in the N.H. State House Wednesday on a vote of 183-159 and has been sent to the State Senate for review.

“Ivermectin is available over the counter in 79 countries,”  State Representative Jim Kofalt, R-Hillsborough noted during a legislative hearing in January. “And it has a good safety profile.”

Read More